Yahoo! Finance Search - Finance Home - Yahoo! - Help

Sunday, August 2 2015 4:21am ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Biotechnology News
Latest News
Saturday, Aug 1, 2015
·The Blockbuster Potential of Biogen Inc's Pipeline
at Motley Fool - Sat 8:59 am ET
·Is This High Risk/High Reward Biotech Stock a Buy?
at Motley Fool - Sat 8:08 am ET
·5 Can't-Miss Quotes From Gilead Sciences Management
at Motley Fool - Sat 7:40 am ET
Friday, Jul 31, 2015
·Cramer Remix: If China falls, buy this stock
at CNBC - Fri 6:59 pm ET
·SECURITIES ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Lawsuit Against CorMedix, Inc. to Recover Investor Losses -- CRMD
GlobeNewswire - Fri 6:23 pm ET
·SECURITIES ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Celladon Corporation -- CLDN
GlobeNewswire - Fri 6:10 pm ET
·Bay Area obesity drug maker slims down as market slows
at bizjournals.com - Fri 5:55 pm ET
·Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire - Fri 5:15 pm ET
·Omeros Corporation to Announce Second Quarter 2015 Financial Results on August 10, 2015
PR Newswire - Fri 4:50 pm ET
·Amgen raises profit outlook after posting a strong second quarter
at bizjournals.com - Fri 4:45 pm ET
·Express Scripts excludes 20 more drugs from 2016 coverage
Reuters - Fri 4:24 pm ET
·Five Prime Therapeutics to Announce Second Quarter 2015 Financial Results and Host Conference Call on August 6
GlobeNewswire - Fri 4:05 pm ET
·ImmunoGen: Back to a Development-Stage Biotech
at Motley Fool - Fri 4:00 pm ET
·Amgen (AMGN) Stock Higher as Barclays Increases Price Target
at TheStreet.com - Fri 3:31 pm ET
·Vivus (VVUS) Stock Falls Following Earnings Release, Restructuring Plan
at TheStreet.com - Fri 3:25 pm ET
·Kite Pharma Takes Flight And Retreats
- Fri 2:52 pm ET
·Amgen Crushes Wall Street's Expectations in Q2, But This Figure Is a Bit Worrisome
at Motley Fool - Fri 2:41 pm ET
·ADMA Biologics Files BLA for RI-002 with FDA Approval on Track for Second Half of 2016
- Fri 1:45 pm ET
·Insight Into Earnings Is Sending Medivation, Inc. Shares Soaring Today
at Motley Fool - Fri 1:34 pm ET
·Cleveland BioLabs Announces Date Change for Second Quarter 2015 Financial Results
Marketwire - Fri 1:00 pm ET
More Latest News...
Sponsor Results
Synthetic Biotechnology
Monthly peer review journal. Elsevier and CSPM join forces
www.keaipublishing.com
MS in Regulatory Science
Johns Hopkins University Evenings, weekends and online
regulatory.jhu.edu
Managed Care Research
Digital Trends In the Payer Marketplace
hobartgroupholdings.com/
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?